DK1005458T3 - Carbostyrilderivater til inhibering af huderytem og/eller hudpigmentering - Google Patents

Carbostyrilderivater til inhibering af huderytem og/eller hudpigmentering

Info

Publication number: DK1005458T3
Authority: DK; Denmark
Prior art keywords: skin; rhythm; inhibiting; carbostyril derivatives; pigmentation
Prior art date: 1997-08-19

Application number

DK98937851T

Other languages

English (en)

Inventor

Yasuo Oshiro

Takao Nishi

Keiichi Kuwahara

Kozo Watanabe

Original Assignee

Otsuka Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-19

Filing date

1998-08-18

Publication date

2005-01-31

1998-08-18 Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd

2005-01-31 Application granted granted Critical

2005-01-31 Publication of DK1005458T3 publication Critical patent/DK1005458T3/da

Links

208000012641 Pigmentation disease Diseases 0.000 title 1
230000002401 inhibitory effect Effects 0.000 title 1
LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title 1
230000033764 rhythmic process Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Quinoline Compounds (AREA)

DK98937851T 1997-08-19 1998-08-18 Carbostyrilderivater til inhibering af huderytem og/eller hudpigmentering DK1005458T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP22243197		1997-08-19
EP98937851A EP1005458B1 (en)	1997-08-19	1998-08-18	Carbostyril derivatives for inhibiting skin erythema and/or skin pigmentation
PCT/JP1998/003657 WO1999009011A1 (en)	1997-08-19	1998-08-18	Carbostyril derivatives for inhibiting skin erythema and/or skin pigmentation

Publications (1)

Publication Number	Publication Date
DK1005458T3 true DK1005458T3 (da)	2005-01-31

Family

ID=16782296

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98937851T DK1005458T3 (da)	1997-08-19	1998-08-18	Carbostyrilderivater til inhibering af huderytem og/eller hudpigmentering

Country Status (19)

Country	Link
US (1)	US6133264A (da)
EP (1)	EP1005458B1 (da)
JP (1)	JPH11124366A (da)
KR (1)	KR100397201B1 (da)
CN (1)	CN1141298C (da)
AR (1)	AR013945A1 (da)
AT (1)	ATE279395T1 (da)
AU (1)	AU725464B2 (da)
BR (1)	BR9811307A (da)
CA (1)	CA2297439C (da)
DE (1)	DE69827014T2 (da)
DK (1)	DK1005458T3 (da)
EG (1)	EG24161A (da)
ES (1)	ES2232001T3 (da)
ID (1)	ID23521A (da)
MY (1)	MY115907A (da)
PT (1)	PT1005458E (da)
TW (1)	TW436483B (da)
WO (1)	WO1999009011A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020034772A1 (en)	1999-06-29	2002-03-21	Orlow Seth J.	Methods and compositions that affect melanogenesis
US20020114769A1 (en) *	2000-09-14	2002-08-22	Rotenberg Susan A.	Novel dequalinium analogs
WO2011094016A1 (en)	2010-01-28	2011-08-04	New York University	Compounds, compositions and methods for preventing skin darkening
WO2012103487A1 (en)	2011-01-27	2012-08-02	New York University	Coumarin compounds as melanogenesis modifiers and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1219587A (en) *	1981-12-14	1987-03-24	Norman P. Jensen	Hydroxybenzylaminobenzenes as anti-inflammatory agents
US5082847A (en) *	1990-07-18	1992-01-21	Syntex (U.S.A.) Inc.	Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility
US5576324A (en) *	1992-05-01	1996-11-19	Kowa Co., Ltd.	Quinoline derivatives or salt thereof and remedy for cardiac diseases containing the same
TW448161B (en) *	1994-07-14	2001-08-01	Otsuka Pharma Co Ltd	Cyclic amide derivatives
JP3042894B2 (ja) *	1995-07-07	2000-05-22	ファイザー製薬株式会社	サブスタンスｐアンタゴニストとしての置換ベンゾラクタム化合物
EP0918522A4 (en) *	1996-05-20	1999-08-18	Merck & Co Inc	GONADOLIBERIN ANTAGONISTS
WO1997044321A1 (en) *	1996-05-20	1997-11-27	Merck & Co., Inc.	Antagonists of gonadotropin releasing hormone

1998
- 1998-07-23 TW TW087112066A patent/TW436483B/zh not_active IP Right Cessation
- 1998-08-13 EG EG94298A patent/EG24161A/xx active
- 1998-08-17 JP JP10230407A patent/JPH11124366A/ja active Pending
- 1998-08-18 US US09/485,454 patent/US6133264A/en not_active Expired - Fee Related
- 1998-08-18 DK DK98937851T patent/DK1005458T3/da active
- 1998-08-18 DE DE69827014T patent/DE69827014T2/de not_active Expired - Fee Related
- 1998-08-18 CN CNB988082772A patent/CN1141298C/zh not_active Expired - Fee Related
- 1998-08-18 MY MYPI98003752A patent/MY115907A/en unknown
- 1998-08-18 AT AT98937851T patent/ATE279395T1/de not_active IP Right Cessation
- 1998-08-18 EP EP98937851A patent/EP1005458B1/en not_active Expired - Lifetime
- 1998-08-18 ID IDW20000312A patent/ID23521A/id unknown
- 1998-08-18 ES ES98937851T patent/ES2232001T3/es not_active Expired - Lifetime
- 1998-08-18 CA CA002297439A patent/CA2297439C/en not_active Expired - Fee Related
- 1998-08-18 WO PCT/JP1998/003657 patent/WO1999009011A1/en not_active Ceased
- 1998-08-18 KR KR10-2000-7001705A patent/KR100397201B1/ko not_active Expired - Fee Related
- 1998-08-18 PT PT98937851T patent/PT1005458E/pt unknown
- 1998-08-18 BR BR9811307-0A patent/BR9811307A/pt not_active IP Right Cessation
- 1998-08-18 AU AU86500/98A patent/AU725464B2/en not_active Ceased
- 1998-08-18 AR ARP980104065A patent/AR013945A1/es active IP Right Grant

Also Published As

Publication number	Publication date
KR20010023086A (ko)	2001-03-26
CA2297439C (en)	2006-12-19
CA2297439A1 (en)	1999-02-25
CN1141298C (zh)	2004-03-10
AU725464B2 (en)	2000-10-12
BR9811307A (pt)	2000-08-29
TW436483B (en)	2001-05-28
AR013945A1 (es)	2001-01-31
JPH11124366A (ja)	1999-05-11
US6133264A (en)	2000-10-17
MY115907A (en)	2003-09-30
DE69827014T2 (de)	2005-03-17
KR100397201B1 (ko)	2003-09-13
ATE279395T1 (de)	2004-10-15
ID23521A (id)	2000-04-27
PT1005458E (pt)	2005-01-31
EG24161A (en)	2008-08-20
HK1029346A1 (en)	2001-03-30
EP1005458A1 (en)	2000-06-07
AU8650098A (en)	1999-03-08
ES2232001T3 (es)	2005-05-16
EP1005458B1 (en)	2004-10-13
DE69827014D1 (de)	2004-11-18
WO1999009011A1 (en)	1999-02-25
CN1267284A (zh)	2000-09-20

Publication	Publication Date	Title
NO995784D0 (no)	1999-11-25	Fytosterol og/eller fytosterolderivater
ID17948A (id)	1998-02-12	Piridine bersumbu heterosiklik
DK1454907T3 (da)	2009-03-09	Quninazolin og pyridopyrmidin-derivativer
DK0948308T3 (da)	2004-06-14	Fremgangsmåder til behandling af hudpigmentering
DE19983155T1 (de)	2001-06-13	Persönliches Identifikationssystem und Verfahren
IS6385A (is)	2002-05-15	Ný notkun og nýjar N-asabísýkló-amíð afleiður
DE69732503D1 (de)	2005-03-24	Hautalterungsschutzmittel
EE200000279A (et)	2001-10-15	Ravimi nahka penetreerumist suurendavad komponendid
NO20000996D0 (no)	2000-02-28	Kombinasjonsterapi omfattende atorvastatin og et antihypertensivt middel
ATE225784T1 (de)	2002-10-15	Indan- oder dihydroindolderivate
NO20003067D0 (no)	2000-06-15	Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
NO991701D0 (no)	1999-04-09	HIV og cancer behandling
DE69903143D1 (de)	2002-10-31	Chromanon und thiochromanon derivate
DK0926985T3 (da)	2004-02-23	Forbedringer vedrørende hudpunkteringsapparater
NO985307L (no)	1999-01-12	Distamycinderivater, fremgangsmÕte for deres fremstilling, og deres anvende
NO952171D0 (no)	1995-06-01	3-heteroalifatyl- og 3-hetero(aryl)alifatyl-2(1H)-chinolon-derivater
FI965238L (fi)	1996-12-27	Aryyli- ja heteroaryylialkoksinaftaleenijohdannaiset
PT1084126E (pt)	2005-03-31	Novos derivados de vinca-alcaloides e processos de preparacao
NO984921D0 (no)	1998-10-22	Tienopyridinderivater og deres anvendelse
ID16978A (id)	1997-11-27	Zat pelindung kulit
DE69830259D1 (de)	2005-06-30	Gewebeschutzmittel und der Gebrauch desselben
DE69816620D1 (de)	2003-08-28	Hautschutzmittel
NO976052D0 (no)	1997-12-22	Fremgangsmåte og system for seriefeilvern
DK1042286T3 (da)	2010-12-13	Gamme-glutamyl- og beta-aspartyl-holdige immunmodulerende forbindelser og tilhørense fremgangsmåder
DE69802908D1 (de)	2002-01-24	Salicylsäure - sphingoidbase derivate und ihre verwendung